ACRO Clinical

Executive Summary

ACRO Clinical is a boutique Contract Research Organization (CRO) headquartered in San Diego, specializing in full-service clinical trial management from start-up to close-out. Founded in 2010, the company differentiates itself through a strategic, risk-based approach and the use of modern Electronic Data Capture (EDC) systems, ensuring efficient and compliant trial execution for biotech and pharmaceutical sponsors. Its comprehensive services include advanced project management, regulatory compliance, clinical operations, data management, and training, positioning it as a nimble partner for complex and early-stage studies. In a competitive CRO landscape, ACRO Clinical's focus on technology-enabled risk management and personalized service addresses a growing demand for adaptive and cost-effective clinical solutions. While the company remains private and relatively small, its boutique model allows for high client engagement and flexibility. Future growth will depend on its ability to secure repeat business and expand its therapeutic expertise. Key catalysts include new contract wins, potential strategic partnerships, and adoption of decentralized trial capabilities. The overall outlook is positive but tempered by competition and the need for sustained client acquisition.

Upcoming Catalysts (preview)

• Q3 2026New Major Contract Win with a Mid-Size Biotech60% success
• TBDLaunch or Partnership for Decentralized Clinical Trial Technology40% success
• TBDExpansion into a New Therapeutic Area (e.g., Oncology or Rare Diseases)45% success